Sort   by:  
 Page size 
Genomicsena-DATASET-GBM-18-12-2014-13:16:58:171-201 - samples
Description not provided
EGAD00001001110 | EGA
GenomicsGBM_Triplet_GWSNP6_Case - samples
Case samples using SNP 6.0 Array
EGAD00010000656 | EGA
Genomicsena-DATASET-GBM-18-12-2014-13:23:12:439-204 - samples
Description not provided
EGAD00001001112 | EGA
Genomicsena-DATASET-GBM-18-12-2014-13:35:47:554-206 - samples
Description not provided
EGAD00001001113 | EGA
Genomicsena-DATASET-GBM-18-12-2014-13:21:42:962-203 - samples
Description not provided
EGAD00001001111 | EGA
Genomicsena-DATASET-GBM-18-12-2014-13:14:47:525-200 - samples
Description not provided
EGAD00001001109 | EGA
GenomicsGBM_Triplet_GWSNP6_Control - samples
Control samples using SNP 6.0 Arrays
EGAD00010000654 | EGA
GenomicsSpatial and temporal genomic evolution in glioblastoma
Tumor heterogeneity is a challenging barrier to successful targeted therapy in glioblastoma. Identifying the mechanisms that drive cancer cells as they genetically evolve and adapt in response to treatment is a vital goal of modern cancer research. Analysis of sequencing data provides a method for u...
EGAS00001001033 | EGA
GenomicsVerhaak-GBM
Data Access Committee EGAC00001000268
EGAC00001000268 | EGA
GenomicsNational Cancer Institute Genome-Wide Association Study of Renal Cell Carcinoma

The National Cancer Institute (NCI) genome-wide association study (GWAS) of renal cell carcinoma (RCC) was conducted to investigate common genetic variants associated with RCC risk. The GWAS includes 1,453 RCC cases and 3,531 controls of European background from 4 studies (3 cohort, 1 case-con...

phs000351.v1.p1 | EGA
Sort   by:  
 Page size